Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma

被引:13
|
作者
Terai, Mizue [1 ]
Shimada, Ayako [2 ]
Chervoneva, Inna [2 ]
Hulse, Liam [1 ]
Danielson, Meggie [1 ]
Swensen, Jeff [3 ]
Orloff, Marlana [1 ]
Wedegaertner, Philip B. [4 ]
Benovic, Jeffrey L. [4 ]
Aplin, Andrew E. [5 ]
Sato, Takami [1 ]
机构
[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA
[3] Caris Life Sci, Mol Genet, Phoenix, AZ 85040 USA
[4] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA
[5] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA
关键词
uveal melanoma; metastasis; metastatic uveal melanoma; survival; GNA11; GNAQ; Q209P; Q209L; BAP1; SF3B1; ONCOGENIC MUTATIONS; GNAQ; SURVIVAL;
D O I
10.3390/cancers13225749
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. More than 90% of UMs harbor mutually exclusive activating mutations in G-proteins. The mutations are early events in UM development and considered to be driver mutations in carcinogenesis. Even after treatment of primary uveal melanoma, up to 50% of patients subsequently develop recurrence, predominantly in the liver. GNAQ mutations are not reported to be correlated to survival, while the mutations in GNA11 are reported more frequently in metastatic UM. We investigated the correlation of survival after development of metastasis (Met-to-Death) of metastatic uveal melanoma (MUM) patients with GNA11 and GNAQ mutations. We identified that MUM with mutation patterns of Q209P vs. Q209L in GNA11 and GNAQ might predict survival of MUM patients. Uveal melanoma is the most common primary ocular malignancy in adults, characterized by gene mutations in G protein subunit alpha q (GNAQ) and G protein subunit alpha 11 (GNA11). Although they are considered to be driver mutations, their role in MUM remains elusive. We investigated key somatic mutations ofMUM and their impact on patients' survival after development of systemic metastasis (Met-to-Death). Metastatic lesions from 87 MUM patients were analyzed by next generation sequencing (NGS). GNA11 (41/87) and GNAQ (39/87) mutations were most predominantly seen in MUM. Most GNA11 mutations were Q209L (36/41), whereas GNAQ mutations comprised Q209L (14/39) and Q209P (21/39). Epigenetic pathway mutations BAP1 (42/66), SF3B1 (11/66), FBXW7 (2/87), PBRM1 (1/66), and SETD2 (1/66) were found. No specimen had the EIF1AX mutation. Interestingly, Met-to-Death was longer in patients with GNAQ Q209P compared to GNAQ/GNA11 Q209L mutations, suggesting the difference in mutation type in GNAQ/GNA11 might determine the prognosis of MUM. Structural alterations of the GNAQ/GNA11 protein and their impact on survival of MUM patients should be further investigated.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma
    Moore, Amanda R.
    Ceraudo, Emilie
    Sher, Jessica J.
    Guan, Youxin
    Shoushtari, Alexander N.
    Chang, Matthew T.
    Zhang, Jenny Q.
    Walczak, Edward G.
    Kazmi, Manija A.
    Taylor, Barry S.
    Huber, Thomas
    Chi, Ping
    Sakmar, Thomas P.
    Chen, Yu
    NATURE GENETICS, 2016, 48 (06) : 675 - +
  • [22] Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma
    Amanda R Moore
    Emilie Ceraudo
    Jessica J Sher
    Youxin Guan
    Alexander N Shoushtari
    Matthew T Chang
    Jenny Q Zhang
    Edward G Walczak
    Manija A Kazmi
    Barry S Taylor
    Thomas Huber
    Ping Chi
    Thomas P Sakmar
    Yu Chen
    Nature Genetics, 2016, 48 : 675 - 680
  • [23] Prognostic testing of uveal melanoma
    McLean, IW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S185 - S185
  • [24] Prognostic factors in uveal melanoma
    Singh, AD
    Shields, CL
    Shields, JA
    MELANOMA RESEARCH, 2001, 11 (03) : 255 - 263
  • [25] Prognostic FNAB of Uveal Melanoma
    Singh, Arun
    Aronow, Mary
    Biscotti, Charles
    Tubbs, Raymond
    Schoenfield, Lynn
    Triozzi, Pierre
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [26] Differential modulation and prognostic values of immune-escape genes in uveal melanoma
    Basile, Maria Sofia
    Mazzon, Emanuela
    Russo, Andrea
    Mammana, Santa
    Longo, Antonio
    Bonfiglio, Vincenza
    Fallico, Matteo
    Caltabiano, Rosario
    Fagone, Paolo
    Nicoletti, Ferdinando
    Avitabile, Teresio
    Reibaldi, Michele
    PLOS ONE, 2019, 14 (01):
  • [27] The prognostic values of m6A RNA methylation regulators in uveal melanoma
    Tang, Jing
    Wan, Qi
    Lu, Jianqun
    BMC CANCER, 2020, 20 (01)
  • [28] The prognostic values of m6A RNA methylation regulators in uveal melanoma
    Jing Tang
    Qi Wan
    Jianqun Lu
    BMC Cancer, 20
  • [29] Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma
    Waninger, Jessica J. J.
    Fecher, Leslie A. A.
    Lao, Christopher
    Yentz, Sarah
    Green, Michael D. D.
    Demirci, Hakan
    CANCERS, 2022, 14 (23)
  • [30] Cytomorphometric parameters and the metastatic potential of cutaneous and uveal melanoma - A comparison with prognostic factors
    Pereira, FB
    Burnier, MN
    Shibata, H
    Wang, B
    Carey, W
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2001, 23 (04) : 304 - 307